zofenopril has been researched along with Blood Pressure, High in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.33) | 18.7374 |
| 1990's | 3 (8.33) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, G; Borghi, C; Mancia, G; Van De Borne, P | 1 |
| Allagnat, F; Corpataux, JM; Déglise, S; Deslarzes-Dubuis, C; Lambelet, M; Longchamp, A; Macabrey, D; Ozaki, CK | 1 |
| Heiman, F; Meto, S; Peduto, I; Pegoraro, V; Volpe, M | 1 |
| Ambrosio, G; Ambrosioni, E; Bacchelli, S; Borghi, C; Cicero, AF; Esposti, DD; Omboni, S; Vinereanu, D; Zava, D | 1 |
| Agabiti-Rosei, E; Manolis, A; Omboni, S; Zava, D | 1 |
| Borghi, C; Omboni, S | 1 |
| Dralova, OV; Ermolaeva, AS; Maksimov, ML | 1 |
| Arca, M; Berra, S; Bucci, M; Calabrò, P; Fulgheri, PL; Ghione, S; Modesti, PA; Omboni, S; Pirvu, O; Popescu, E; Portaluppi, F; Pozzilli, P; Taddei, S; Velican, VG; Villani, GQ; Vladoianu, M; Volpe, M | 1 |
| Carrón, R; Gómez-Roso, M; Montero, MJ; Sevilla, MA | 2 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D; Omboni, S; Reggiardo, G | 1 |
| Agabiti-Rosei, E; Borghi, C; Malacco, E; Manolis, A; Modesti, PA; Napoli, C; Omboni, S; Parati, G | 1 |
| Bruzzese, G; Cacciatore, F; Crimi, E; de Nigris, F; Fiorito, C; Ignarro, LJ; Libardi, S; Liguori, A; Mancini, FP; Napoli, C; Sommese, L; Williams-Ignarro, S | 1 |
| Malacco, E; Omboni, S; Parati, G | 1 |
| Bruzzese, G; Cacciatore, F; de Nigris, F; Donatelli, F; Fiorito, C; Ignarro, LJ; Infante, T; Liguori, A; Minucci, PB; Napoli, C; Vitale, DF | 1 |
| Abuladze, GV; Erkomaishvili, IG; Narsiia, EV; Nebieridze, MI; Pipiia, NG | 1 |
| Angelescu, G; Bălan, H; Popescu, E | 1 |
| Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Condorelli, M; de Nigris, F; Ignarro, LJ; Liguori, A; Napoli, C; Pignalosa, O; Sica, V | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Alcaraz, A; Atucha, NM; Evangelista, S; García-Estañ, J; Navarro, EG; O'Valle, F; Ortiz, MC; Vargas, F | 1 |
| Malacco, E; Parati, G; Zanchetti, A | 1 |
| Borghi, C; Cicero, AF | 1 |
| Ambrosioni, E | 1 |
| Boccioletti, V; Cominacini, L; Fabrizzi, P; Garbin, U; Lo Cascio, V; Luchetta, ML; Nava, MC; Pasini, AF; Pellegrini, M; Stranieri, C | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K | 1 |
| Narkiewicz, K | 1 |
| Farsang, C | 1 |
| Mallion, JM | 1 |
| Nilsson, P | 1 |
| Finn, PV; Mitchell, GF; Pfeffer, JM; Pfeffer, MA | 1 |
| Elijovich, F; Laffer, CL; Schiffrin, EL | 1 |
| Ambrosioni, E; Bacchelli, S; Bignamini, A; Borghi, C; Esposti, DD; Magnani, B | 1 |
| Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
| Lacourcière, Y; Provencher, P | 1 |
| Gagné, C; Lacourcière, Y | 1 |
10 review(s) available for zofenopril and Blood Pressure, High
| Article | Year |
|---|---|
Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.
Topics: Animals; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Captopril; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Risk Factors | 2014 |
[Modem inhibitor angiotensin-converting enzyme zofenopril in the primary and secondary prevention of cardiovascular disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Hypertension; Myocardial Ischemia; Outcome Assessment, Health Care; Renin-Angiotensin System | 2014 |
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Captopril; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation Mediators; Irbesartan; Lipids; Male; Middle Aged; Pulse Wave Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Vascular Stiffness | 2017 |
Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Metabolic Diseases | 2009 |
[Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diabetic Cardiomyopathies; Heart Failure; Humans; Hypertension; Myocardial Infarction | 2011 |
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Heart; Humans; Hypertension; Myocardial Infarction | 2004 |
Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2006 |
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Severity of Illness Index; Treatment Outcome | 2006 |
Defining the role of zofenopril in the management of hypertension and ischemic heart disorders.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Drug Administration Schedule; Humans; Hypertension; Myocardial Ischemia; Treatment Outcome | 2007 |
17 trial(s) available for zofenopril and Blood Pressure, High
| Article | Year |
|---|---|
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Captopril; Europe; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Ventricular Dysfunction, Left | 2013 |
Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Captopril; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2014 |
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Systole; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2016 |
Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors | 2017 |
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carotid Arteries; Carotid Stenosis; Dinoprost; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carotid Arteries; Cell Count; Cell Movement; Cells, Cultured; Enalapril; Endothelial Cells; Follow-Up Studies; Humans; Hypertension; Isoprostanes; Middle Aged; Nitrates; Nitrites; Regression Analysis; Stem Cells; Treatment Outcome; Tunica Intima; Ultrasonography | 2011 |
Comparing different treatment schedules of Zomen (zofenopril).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Dose-Response Relationship, Drug; Drug Chronotherapy; Female; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2011 |
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress | 2004 |
Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cell Adhesion Molecules; Cholesterol, HDL; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Ramipril; Sulfhydryl Compounds; Triglycerides; Vasodilation | 2007 |
Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Office Visits | 2007 |
Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2007 |
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Time Factors; Treatment Outcome | 2007 |
The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
Topics: Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Captopril; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Hypertension | 1997 |
Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome; Ventricular Function, Left | 1999 |
Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Monitoring, Physiologic | 1989 |
Influence of zofenopril and low doses of hydrochlorothiazide on plasma lipoproteins in patients with mild to moderate essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Captopril; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Randomized Controlled Trials as Topic | 1989 |
9 other study(ies) available for zofenopril and Blood Pressure, High
| Article | Year |
|---|---|
Zofenopril: Blood pressure control and cardio-protection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Humans; Hypertension; Myocardial Ischemia | 2022 |
Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Carotid Stenosis; Cells, Cultured; Disease Models, Animal; Humans; Hydrogen Sulfide; Hyperplasia; Hypertension; Male; Mice; Myocytes, Smooth Muscle; Organ Culture Techniques; Primary Cell Culture; Tunica Intima; Veins | 2022 |
Extemporaneous combination therapy with nebivolol/zofenopril in hypertensive patients: usage in Italy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Hypertension; Hypoglycemic Agents; Lipids; Male; Medication Adherence; Nebivolol; Retrospective Studies | 2022 |
Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Cardiomegaly; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hydroxyproline; Hypertension; Male; Myocardium; Rats, Wistar; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2016 |
Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluorometry; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2009 |
Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine | 2006 |
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Controlled Clinical Trials as Topic; History, 20th Century; History, 21st Century; Humans; Hypertension; Myocardial Infarction | 2007 |
Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Captopril; Cardiomegaly; Hemodynamics; Hydralazine; Hypertension; Male; Pulsatile Flow; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Remission Induction; Ventricular Function, Left; Water | 1996 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |